Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/renibus-therapeutics-announces-presentation-at-oppenheimer-34th-annual-healthcare-conference-302055962.html
https://www.prnewswire.com/news-releases/renibus-announces-publication-of-results-from-phase-2-study-evaluating-rbt-1-as-a-pre-conditioning-agent-to-reduce-post-operative-complications-following-cardiothoracic-surgery-302029800.html
https://www.prnewswire.com/news-releases/renibus-announces-first-patient-enrolled-in-protect-phase-3-study-of-rbt-1-to-reduce-post-operative-complications-after-cardiothoracic-surgery-301967256.html
https://www.prnewswire.com/news-releases/renibus-therapeutics-announces-participation-at-upcoming-investor-conferences-301952536.html
https://www.prnewswire.com/news-releases/renibus-therapeutics-announces-final-close-of-upsized-series-b-financing-bringing-total-round-to-72-million-301923892.html
https://endpts.com/exclusive-texas-biotech-raises-47m-to-move-heart-surgery-drug-into-pivotal-study/
https://www.prnewswire.com/news-releases/renibus-therapeutics-announces-breakthrough-therapy-designation-from-us-fda-for-rbt-1-for-the-reduction-in-risk-of-post-operative-complications-in-patients-undergoing-cardiothoracic-surgery-301873635.html
https://www.prnewswire.com/news-releases/renibus-reports-positive-final-results-from-phase-2-study-of-rbt-1-a-first-in-class-preconditioning-agent-for-patients-undergoing-cardiothoracic-surgery-at-the-american-association-for-thoracic-surgery-aats-meeting-301817779.html
https://www.prnewswire.com/news-releases/renibus-therapeutics-announces-presentation-at-22nd-annual-needham-virtual-healthcare-conference-301790693.html
https://www.prnewswire.com/news-releases/renibus-therapeutics-announces-presentation-at-oppenheimer-33rd-annual-healthcare-conference-301765071.html